Guselkumab biosimilar (Polpharma Biologics)

N/A

Report date: 2025/09/03 17:00:12

Base Information

Drug NameGuselkumab biosimilar (Polpharma Biologics)
Drug Alias NamePB019PB-019
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionInterleukin-23 subunit p19 inhibitors
TargetsInterleukin-23 subunit p19
Therapy Area/IndicationsPlaque psoriasisArthritis, Psoriatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPolpharma Biologics Sa
China Registration ClassN/A

Develop Information

Active CompaniesPolpharma Biologics Sa
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisArthritis, Psoriatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A